ADMA Biologics: Ending 2026 On A High Note

ADMA Biologics reported strong earnings for 2026, with revenue growth driven by its plasma-derived therapies.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.